Let’s Stop the #1 Killer of Americans Today

More than 7 million Americans suffer from coronary heart disease (CHD), the most common form of heart disease. Regardless of your age or condition, adding CardioForLIfe® to your daily regimen will dramatically improve your cardiovascular health.

CardioForLIfe® has been the top-selling Arginine product in the marketplace for more than six years. Formulated by Dr. Harry Elwardt, N.D., Ph.D. and best-selling author of “Let’s Stop the #1 Killer of Americans Today”, Dr. Harry believes together we can slow and potentially reverse heart disease.

Individual results may vary, read more here https://bit.ly/covid19go

Natural Heart Health Supplement
CardioForLIfe® is an all natural supplement designed to help with cardiovascular disease. CardioForLIfe® powder comes in four delicious flavors – GRAPE, ORANGE, PEACH and PINA COLADA. It dissolves quickly and easily in water. CardioForLIfe® is also available in chewables in CHOCOLATE and BERRY flavors.

Nitric Oxide Investigated as COVID-19 Treatment
I have been saying for quite some time that Cardioforlife® will help keep the Corona Virus at bay. Arginine derived nitric oxide, as created by the 5 grams of arginine in Cardioforlife®. It is proven to boost the B-cell and T-cell count which are your army of defenders against all bacteria and viruses that try to get past your immune system.

Arginine derived nitric oxide also increases oxygen to every cell of the body which is why people with asthma, COPD and other lung ailments see immediate benefits. Now I feel fully vindicated by reading what was just published in the WEB MD article below.

I have also shared in the past, that studies show that people of color produce less nitric oxide which is why 40% of the corona virus fatalities are people of color even though they are only 13% of the US population. So, increasing nitric oxide in the blood stream is paramount for everyone’s survival.

Please share this life saving information with your family and friends.

WebMD THURSDAY, April 9, 2020 (HealthDay News) — Doctors at the University of Alabama at Birmingham (UAB) are enrolling patients in an international clinical trial to find out if inhaled nitric oxide benefits those with COVID-19 who have severely damaged lungs.

Right now, there are no approved treatments for the illness caused by the new coronavirus. A severe form of lung failure called acute respiratory distress syndrome is the leading cause of death in COVID-19.

When lungs are failing, air is received by some parts of them but not others. Nitric oxide is a gas that improves blood flow in areas of the lungs that are getting air, increasing the amount of oxygen in the blood stream. Nitric oxide also reduces the workload of the right side of the heart, which is under extreme stress during lung failure.

Along with being used to treat failing lungs, nitric oxide has been found to have antiviral properties against coronaviruses. That was shown during the 2002-2003 SARS outbreak, which was caused by a coronavirus similar to the one that causes COVID-19.

Any COVID-19 patient in UAB’s intensive care unit who is using a ventilator to breathe may qualify for the study.

“This trial will allow the sickest COVID-19 patients at UAB access to a rescue therapy that may have antiviral benefits in addition to improving the status of lungs,” Dr. Vibhu Parcha said in a university news release. He’s a research fellow in the Division of Cardiovascular Disease.

“In humans, nitric oxide is generated within the blood vessels and regulates blood pressure and prevents the formation of clots and also destroys potential toxins,” said Dr. Pankaj Arora, an assistant professor of cardiovascular disease. His team plans to study the cardiovascular effects of high dose inhaled nitric oxide as part of the primary clinical trial.

There you have it … proof that Cardioforlife maybe all you need to win the war against the Corona Virus.

Soldier for optimum health,
Dr. Harry Elwardt, ND, Ph.D.
See the product in our online store: Health Guardian

Leave a Reply

Your email address will not be published. Required fields are marked *